May 13, 2026
Chondroitin Sulfate Sourcing in 2026: What 240 Million Osteoarthritis Patients Mean For Supply
Osteoarthritis affects over 240 million people worldwide. And the number of people over 60 is set to double by 2050. Here's what that means for the chondroit...
-
![The Yasheng Pharmaceutical Eed Inhibitor Apg-5918 Was Approved By A Chinese P...]()
Nov 10, 2022The Yasheng Pharmaceutical Eed Inhibitor Apg-5918 Was Approved By A Chinese P...Sheng medicine on November 10 (today) in its WeChat public announcement said (the original below), the company in research original new class 1 emb...view more -
![MSD PD-1 Was Approved As The 10th Indication in China]()
Nov 10, 2022MSD PD-1 Was Approved As The 10th Indication in ChinaNovember 9, 2022 -- Merck announces that its PD-1 inhibitor, Parbolizumab (trade name: Kerida ®️) has been approved by the National Medical Product...view more -
![Respiratory Syncytial Virus (Rsv) Prevention Milestones! Single-Dose Passive ...]()
Nov 09, 2022Respiratory Syncytial Virus (Rsv) Prevention Milestones! Single-Dose Passive ...Beyfortus is the first single-dose prophylaxis approved for RSV, and is also the first and only RSV prophylaxis for a wide population of newborns a...view more -
![The 11th Annual Meeting Of Medidata NEXT in 2022, The Sub-conference Of Digit...]()
Nov 09, 2022The 11th Annual Meeting Of Medidata NEXT in 2022, The Sub-conference Of Digit...On the afternoon of October 26th, the 11th Medidata NEXT China Annual Meeting 2022 Suzhihua Drug Research and Development sub-conference was held o...view more -
![Chronic Kidney Disease (Ckd) New Drug! Sglt2 Inhibitor Jardiance (Engleazin) ...]()
Nov 08, 2022Chronic Kidney Disease (Ckd) New Drug! Sglt2 Inhibitor Jardiance (Engleazin) ...Jardiance (O'Tangjing, Englegrizin) is an oral, once-daily, highly selective SGLT-2 inhibitor that has been approved for marketing in China.view more -
![Astrazeneca, Ramping Up Chinese Medicine]()
Nov 07, 2022Astrazeneca, Ramping Up Chinese MedicineChinese medicine innovation, further Following Astrazeneca's cooperation with Chengdu High-tech Zone to build a TCM innovation industry base, Astra...view more -
![Cell Death Dis: Uncovers The Molecular Mechanisms By Which Human Brain Neuron...]()
Nov 07, 2022Cell Death Dis: Uncovers The Molecular Mechanisms By Which Human Brain Neuron...Scientists from Germany have investigated the cellular resilience of neurons in human neurons; they use human induced pluripotent stem cells (iPSCs...view more -
![SERD Targets,a Star Of Hope Strikes]()
Nov 07, 2022SERD Targets,a Star Of Hope StrikesBreast cancer is the most common malignancy in the world, with 2.26 million new cases in 2020, accounting for 11.7% of the total incidence of cance...view more -
![The First Domestic Innovative Anti-depressant Drug Has Been Approved]()
Nov 04, 2022The First Domestic Innovative Anti-depressant Drug Has Been ApprovedOn November 3, Luye Pharma made a blockbuster announcement on its wechat official account: Luye Pharma Group announced that its self-developed Clas...view more -
![More Expensive Than The Car-t! What Are The Advantages Of Johnson & Johnson B...]()
Nov 03, 2022More Expensive Than The Car-t! What Are The Advantages Of Johnson & Johnson B...On October 25th, the FDA approved Johnson & Johnson's BCMA / CD3 dual-resistant Teclistamab for relapsed and refractory multiple myeloma (MM), unde...view more -
![A New Generation Of Medicine King]()
Nov 03, 2022A New Generation Of Medicine KingIn 2012, Sumerol beat Pfizer's Lipitor to become the world's top drug seller with $9.48 billion. At this point, Xiu Meile has been consecutive 9 ye...view more -
![The Battle Between Pfizer And Gilead Over COVID-19 Drugs Will Continue]()
Nov 02, 2022The Battle Between Pfizer And Gilead Over COVID-19 Drugs Will ContinuePfizer reported $7.514 billion in global revenue for its oral drug Paxlovid in the third quarter. Full-year sales guidance of $22 billion was uncha...view more
